Wuhan Nusun Landscape (300536.SZ) and related personnel received a warning letter from the Hubei Securities Regulatory Bureau due to the inaccurate disclosure of performance forecasts.
"Wuhan Nusun Landscape (300536.SZ) issued an announcement that the company recently received the decision from Hubei Securities Regulatory Bureau of China Securities Regulatory Commission, titled 'Decision of Hubei Securities Regulatory Bureau on Issuing Warning Letter Measures to Wuhan Nusun Landscape Co., Ltd., Wu Shixiong, Lin Feng, Luo Xia, Jia Chunqi' ([2023] No. 33).
It is reported that on January 31, 2023, the company disclosed the '2022 Performance Forecast', which estimated the net profit attributable to the shareholders of the listed company to be 4.05 million yuan to 6 million yuan, and the net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses to be 4.25 million yuan to 6.35 million yuan for the year 2022. On March 24, 2023, the company disclosed the '2022 Performance Forecast Amendment Announcement', and after the revision, it is estimated that the net profit attributable to the shareholders of the listed company for 2022 will be 20 million yuan to 25 million yuan, and the net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses will be 20.5 million yuan to 25.5 million yuan. On March 29, 2023, the company disclosed the '2022 Annual Report', which stated that the audited net profit attributable to the shareholders of the listed company for the year 2022 was 23,468,200 yuan. The net profit attributable to the shareholders of the listed company disclosed in the performance forecast, as well as the net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses, and the audited data disclosed in the annual report have a significant difference, indicating inaccurate disclosure in the performance forecast.
The above actions of the company violated Article 3, Paragraph 1 of the 'Administrative Measures for the Disclosure of Information by Listed Companies' (CSRC Order No. 182). Wu Shixiong, as the former chairman of the company, Lin Feng, as the general manager of the company, Luo Xia, as the former CFO of the company, and Jia Chunqi, as the secretary of the board of directors, failed to fulfill their diligent responsibilities in accordance with the provisions of Article 4 and Article 51 of the 'Administrative Measures for the Disclosure of Information by Listed Companies' (CSRC Order No. 182), and bear the main responsibility for the company's above-mentioned violations."
Related Articles

HK Stock Market Move | Giant Biogene (02367) fell more than 3%, hitting a new low for the year. The stock price has been halved from its high point in May. Its ranking in the Double Eleven sales event may decline.

UBS: Hong Kong has emerged from its cyclical downturn, the thriving financial industry foreshadows a period of growth.

Hua Storage Network: Central reserve frozen pork rotation out of storage bidding transaction will be conducted on November 26th.
HK Stock Market Move | Giant Biogene (02367) fell more than 3%, hitting a new low for the year. The stock price has been halved from its high point in May. Its ranking in the Double Eleven sales event may decline.

UBS: Hong Kong has emerged from its cyclical downturn, the thriving financial industry foreshadows a period of growth.

Hua Storage Network: Central reserve frozen pork rotation out of storage bidding transaction will be conducted on November 26th.

RECOMMEND

Tech Stocks, Crypto, and Gold Slump; U.S. Equities Break Key Support Amid Broad-based Sell-off
18/11/2025

Goldman Sachs’ Ten-year Investment Outlook: Artificial Intelligence and Emerging Markets As Core Growth Engines
18/11/2025

Consensus On Multiple Outcomes, Easing Trade Tensions, China–Germany High-level Financial Dialogue Convened In Beijing
18/11/2025


